
US biotech firm Moderna will charge between USD 25 and USD 37 for a dose of the coronavirus vaccine the firm is currently taking through final trials, which Moderna's CEO Stéphane Bancel tells German Sunday newspaper Welt am Sonntag.
"Our vaccine will cost around the same as an influenza vaccine, which costs between USD 10 and USD 50," he says.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app